You're contacting media contact of this press release
Title: My Blood Your Blood Rates CoreAge Rx Its #1 GLP-1 Provider, Highlighting Pharmaceutical-Grade Medications, Medical Oversight, and Transparent Pricing
United States, 27th Feb 2026 - My Blood Your Blood, an independent metabolic health review platform that evaluates GLP-1 telehealth providers through a clinical lens, has named CoreAge Rx its top recommendation for both Semaglutide and Tirzepatide treatment. The platform awarded CoreAge Rx a 4.7 out of 5 overall rating, with top scores across medication quality, medical oversight, pricing, patient experience, and accessibility.My Blood Your Blood evaluated CoreAge Rx against dozens of competing telehealth providers, focusing specifically on medication authenticity, physician supervision, and pricing transparency. The platform concluded that CoreAge Rx stood above competitors on all three fronts, noting that the provider sources pharmaceutical-grade compounded Semaglutide and Tirzepatide through pharmacy partners who maintain proper cold-chain handling and storage protocols to preserve medication stability and effectiveness.The review highlights CoreAge Rx's comprehensive intake process, which includes medical history screening, current medication review, contraindication checks, and baseline metabolic assessment before any prescription is issued. Ongoing support includes regular check-ins, dose adjustment protocols, and direct access to the medical team for questions and concerns throughout treatment. Programs are priced between $99 and $399 per month depending on medication and dose, with all consultation fees, medication costs, and ongoing support bundled into a single flat rate with no hidden fees."Patients need to trust that what they are receiving is exactly what was formulated and that someone with real medical expertise is watching over their care," said a CoreAge Rx spokesperson. "We built this program around those two principles — medication quality...
This press release is issued by King Newswire